Evaluation of the Relationship Between Favipiravir Use and Telogen Effluvium in COVID-19 Patients

May 2023 in “ Journal of contemporary medicine ”

Hanife Merve Akca, Zuhal Metin, Işıl Göğem İmren, Kevser Tuncer Kara

Favipiravir Telogen Effluvium hair loss COVID-19 positive pull test alopecia FVP TE

Studysummary This study observed that patients who received Favipiravir treatment after having COVID-19 had lower positive pull test scores for telogen effluvium hair loss compared to those who did not, suggesting that Favipiravir may not influence the development of telogen effluvium. Our plain-language summary of this paper — not a Tressless recommendation.

The study investigated the link between Favipiravir (FVP), a COVID-19 treatment drug, and Telogen Effluvium (TE), a common type of hair loss. It included patients aged 18-65 who had been diagnosed with COVID-19 in the past year and were experiencing hair loss. The results showed that the majority of FVP users were women (p = 0.027), and the rate of positive pull tests, used to diagnose TE, was significantly higher among those who did not use FVP (p = 0.026). This suggests that FVP may not influence the development of TE. This is the first study to explore the effect of FVP on alopecia and TE.

View this study on dergipark.org.tr →

Discuss this study in the Community →

Research cited in this study

15 / 15 results

research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms

28 citations , January 2021 in “Skin appendage disorders”

This study observed that telogen effluvium, or acute hair loss, often occurs 1 to 3 months after SARS-CoV-2 infection, earlier than classic telogen effluvium.

research Retrospective Evaluation of Patients with the Diagnosis of Telogen Effluvium

1 citations , December 2020 in “Harran Üniversitesi týp fakültesi dergisi”

This study suggests that low serum iron and ferritin levels may be associated with telogen effluvium in patients presenting with hair loss.

research Telogen Effluvium: A Sequela of COVID-19

58 citations , November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations , November 2020 in “Dermatologic Therapy”

This case series reports telogen effluvium in three patients following severe Sars-Cov-2 infection and suggests a potential association that merits further investigation.

research Acute Telogen Effluvium Associated with SARS-CoV-2 Infection

24 citations , August 2020 in “AJGP”

A woman's sudden hair loss was linked to her previous COVID-19 infection.

research Telogen Effluvium: A Review

2 citations , January 2019 in “International Journal of Medicine in Developing Countries”

This review discusses telogen effluvium as a common cause of diffuse hair loss and reports no new clinical results, noting diagnostic and treatment challenges.

research The Role of Vitamin D in Non-Scarring Alopecia

32 citations , December 2017 in “International Journal of Molecular Sciences”

This review suggests that decreased serum 25-hydroxyvitamin D levels may play a role in different types of non-scarring alopecia, but further studies are needed to explore vitamin D supplementation as a therapeutic option.

research Evaluation of Thyroid Autoimmunity in Female Patients with Telogen Effluvium

2 citations , January 2014 in “Türkiye klinikleri tıp bilimleri dergisi”

This study suggests that thyroid autoimmunity may play a role in telogen effluvium pathogenesis, indicating a need for evaluating thyroid autoantibodies in addition to thyroid function tests in these patients.

research Clinical Evaluation of Alopecias Using a Handheld Dermatoscope

66 citations , November 2011 in “Journal of The American Academy of Dermatology”

This study concluded that a polarized-light handheld dermatoscope attached to a digital camera is a practical and useful tool for diagnosing different types of alopecia.

research The Role of Anemia and Vitamin D Levels in Acute and Chronic Telogen Effluvium

11 citations , January 2011 in “Turkish Journal of Medical Sciences”

This study found that iron deficiency anemia is a key factor in the development of telogen effluvium, and higher 25-hydroxyvitamin D3 levels in TE patients may be linked to increased UV exposure.

research Diagnosis of Hair Disorders

73 citations , March 2009 in “Seminars in Cutaneous Medicine and Surgery”

This article reviews various diagnostic tools for hair disorders, describing methods ranging from invasive to noninvasive, but reports no new research findings or clinical results.

Clinical Significance of Dermoscopy in Alopecia Areata: Analysis of 300 Cases